Five Prime Therapeutics (FPRX) Surges Over 250% on Positive Bemarituzumab Results
Tweet Send to a Friend
Five Prime Therapeutics (NASDAQ: FPRX) is surging 255% after-hours after it announced positive ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
